- Home
- SMMT vs CAG Comparison
SMMT vs CAG Comparison
Compare SMMT & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMMT
- CAG
- Stock Information
- Founded
- SMMT 2003
- CAG 1919
- Country
- SMMT United States
- CAG United States
- Employees
- SMMT N/A
- CAG N/A
- Industry
- SMMT Biotechnology: Pharmaceutical Preparations
- CAG Packaged Foods
- Sector
- SMMT Health Care
- CAG Consumer Staples
- Exchange
- SMMT Nasdaq
- CAG Nasdaq
- Market Cap
- SMMT 14.5B
- CAG 14.1B
- IPO Year
- SMMT N/A
- CAG N/A
- Fundamental
- Price
- SMMT $18.31
- CAG $26.69
- Analyst Decision
- SMMT Strong Buy
- CAG Hold
- Analyst Count
- SMMT 4
- CAG 8
- Target Price
- SMMT $34.75
- CAG $31.63
- AVG Volume (30 Days)
- SMMT 2.1M
- CAG 4.3M
- Earning Date
- SMMT 10-30-2024
- CAG 01-02-2025
- Dividend Yield
- SMMT N/A
- CAG 5.24%
- EPS Growth
- SMMT N/A
- CAG N/A
- EPS
- SMMT N/A
- CAG 1.02
- Revenue
- SMMT N/A
- CAG $11,941,800,000.00
- Revenue This Year
- SMMT N/A
- CAG N/A
- Revenue Next Year
- SMMT N/A
- CAG $1.44
- P/E Ratio
- SMMT N/A
- CAG $26.16
- Revenue Growth
- SMMT N/A
- CAG N/A
- 52 Week Low
- SMMT $1.88
- CAG $26.21
- 52 Week High
- SMMT $33.89
- CAG $33.24
- Technical
- Relative Strength Index (RSI)
- SMMT 41.16
- CAG 20.82
- Support Level
- SMMT $19.01
- CAG $27.47
- Resistance Level
- SMMT $22.53
- CAG $27.95
- Average True Range (ATR)
- SMMT 1.45
- CAG 0.56
- MACD
- SMMT -0.21
- CAG -0.15
- Stochastic Oscillator
- SMMT 4.85
- CAG 13.01
About SMMT Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
About CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (over 90% of fiscal 2024 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. The company primarily sells through the us retail channel, with just 9% of fiscal 2024 revenue coming from international markets and 10% from foodservice.